









Markets
/
Stocks
/
nasdaq-cai
/

Caris Life Sciences Inc

CAI

29.500USD

+1.980+7.19%

Close 07/30, 16:00（ET）Quotes delayed by 15 min

8.20BMarket Cap

LossP/E TTM



Caris Life Sciences Inc

29.500

+1.980+7.19%

Overview Company Financials

Income Statement

Cash Flow Statement

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

Total equity

Cash, cash equivalents and short-term investments

--33.43M

- Cash and cash equivalents

--31.20M

-Short-term investments

--2.23M

Receivables

--80.17M

-Accounts and notes receivable

--80.17M

Inventory

--36.55M

Prepaid expenses

--11.92M

Other current assets

--9.16M

Total current assets

--171.23M

Non-current assets

Net Fixed Assets

--61.65M

-Fixed Assets

--297.29M

-Accumulated depreciation

--235.64M

Goodwill and other intangible assets

--19.34M

Other non-current assets

--39.35M

Total non-current assets

--120.35M

Total assets

--291.58M

Liabilities

Current liabilities

-Other payables

--0.00

Accrued expenses

--64.22M

Short-term debt and lease liabilities

--60.09M

Deferred liabilities

--7.66M

Other current liabilities

--7.66M

Total current liabilities

--162.55M

Non-current liabilities

Long-term debt and lease liabilities

--353.71M

-Long-term debt

--316.64M

-Long-term lease liabilities

--37.07M

Derivatives liabilities

--380.00K

Other non-current liabilities

--128.69M

Total non-current liabilities

--482.78M

Total liabilities

--645.34M

Shareholders' equity

Common equity

--38.00K

Retained earnings

---2.58B

Capital reserves

--0.00

Less: Treasury stock

--16.92M

Gains losses not affecting retained earnings

--245.00K

Total equity

---353.75M

Currency unit

USD

Audit opinions

--

KeyAI

